Legal Status Overview
Gray AreaVirginia has no statute or Board of Pharmacy regulation that names "peptides," "research chemicals," or research-use-only compounds as a distinct legal category. Instead, whether a given peptide can lawfully be sold, prescribed, or compounded in Virginia depends on the general Virginia Drug Control Act and Board of Pharmacy practice-of-pharmacy and compounding rules, which in turn incorporate the federal FDA framework for approved drugs and for 503A/503B compounding. FDA-approved peptide drugs (like semaglutide/tirzepatide products) are prescription-only medicines under that framework, while non-approved "research use only" peptides like BPC-157 and TB-500 are not lawful for human use or sale as drugs, but Virginia has not created a separate criminal or civil scheme targeting them by name.
Key Points
- Virginia's Code of Virginia Title 54.1, Chapter 33 (Practice of Pharmacy) does not list peptides, BPC-157, TB-500, or "research chemicals" as a defined category, so no Virginia-specific peptide statute exists. [1]
- Virginia's Drug Control Act, Code of Virginia Title 54.1, Chapter 34, governs manufacture, distribution, and dispensing of drugs generally in the state, and unapproved peptide products marketed for human use can implicate this general drug-control framework rather than a peptide-specific rule. [2]
- The Virginia Board of Pharmacy's compounding regulations, found in 18VAC110-20, require pharmacies compounding drugs (including compounded semaglutide, tirzepatide, or peptide preparations) to follow standards that mirror the federal 503A/503B compounding framework administered by the FDA. [3]
- The FDA's 503A and 503B compounding framework allows licensed pharmacies and outsourcing facilities to compound a drug like semaglutide only under specific conditions (such as an active drug shortage or patient-specific clinical need), and this federal framework is the operative standard Virginia pharmacies must follow because Virginia has not enacted its own separate peptide-compounding rule. [4]
- A person cannot lawfully buy or import prescription-class peptide medicines (such as approved GLP-1 drugs) in Virginia without a valid prescription from a licensed practitioner, because Virginia dispensing law requires a prescription for any legend (prescription-only) drug regardless of how it is obtained. [1]
- No Virginia-specific bill, regulation, or Attorney General guidance from the last 2-3 years naming peptides or research chemicals as a distinct legal category was identified in this review; general pharmacy, drug-control, and federal FDA law remain the applicable framework. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- Selling unapproved research-use-only peptides like BPC-157 or TB-500 for human consumption in Virginia would primarily raise issues under federal FDA "unapproved new drug" and misbranding law rather than a distinct Virginia criminal peptide statute, since Virginia has not scheduled these peptides as controlled substances. [4]
- Telehealth prescribing of FDA-approved peptide medicines (e.g., semaglutide/tirzepatide) to Virginia patients is permitted only when performed by a practitioner licensed to prescribe in Virginia and following an appropriate patient evaluation, under general Board of Medicine and Board of Pharmacy prescribing rules rather than a peptide-specific telehealth statute. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Virginia
| BPC-157 | BPC-157 has no FDA-approved human use and is not named in any Virginia statute, so in Virginia it exists in a legal gray zone as an unapproved "research use only" peptide that cannot lawfully be marketed, compounded, or sold for human consumption under federal drug law. [4] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | FDA-approved semaglutide and tirzepatide products (e.g., for diabetes or weight management) are legal in Virginia only as prescription-only medicines dispensed by a licensed pharmacy pursuant to a valid prescription, while compounded (non-brand) versions are legal only when compounded consistent with the federal 503A/503B framework that Virginia's Board of Pharmacy compounding rules incorporate. [3] |
| TB-500 | TB-500, like BPC-157, is not an FDA-approved drug and is not separately named in Virginia law, so it is legally treated in Virginia as an unapproved research chemical that cannot be lawfully sold or marketed for human use even though Virginia has not criminalized simple possession of it. [4] |
| Human Growth Hormone (HGH/somatropin) | Somatropin (HGH) is legal in Virginia only as a prescription-only drug for FDA-approved indications, and federal law separately makes it a criminal offense to distribute or possess HGH for any use not approved by the FDA (such as anti-aging or bodybuilding), a restriction Virginia's general drug-control law also incorporates. [2] |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides in Virginia without a prescription?
No prescription-only peptide medicine (such as an FDA-approved GLP-1 drug) can be lawfully purchased in Virginia without a valid prescription, and unapproved "research use only" peptides like BPC-157 cannot lawfully be sold for human use at all under federal drug law that Virginia pharmacies and retailers must follow. [1]
Is it legal to bring peptides into Virginia when traveling or ordering them online?
Virginia has no specific personal-importation rule for peptides, so bringing in an unapproved peptide for personal use falls into a legal gray area under federal FDA importation law rather than a distinct Virginia statute, and no Virginia-specific source addressing this scenario was found.
Can a Virginia telehealth doctor legally prescribe peptides like semaglutide?
Yes, a practitioner licensed to prescribe in Virginia can prescribe FDA-approved peptide drugs such as semaglutide through telehealth, provided the prescription follows Virginia's general prescribing and patient-evaluation rules rather than any peptide-specific telehealth law.
What happens if someone sells BPC-157 or TB-500 in Virginia?
Selling BPC-157 or TB-500 for human use in Virginia primarily risks federal FDA enforcement for distributing an unapproved new drug or misbranded product, since Virginia has not enacted its own criminal statute specifically targeting these peptides. [4]
Does Virginia Board of Pharmacy regulate compounded peptide products differently from other compounded drugs?
No, the Virginia Board of Pharmacy applies its general compounding regulations under 18VAC110-20 to compounded peptide products the same way it does to other compounded drugs, requiring compliance with the federal 503A/503B compounding standards rather than a peptide-specific rule. [3]